Bioinformatics News Nov 2007: bioinformatics, genomics, proteomics, microarray, etc.

Previous 1 2 3 4 Next

FPGA-based solution interfaces to Intel bus
The Xilinx ACP M1 FPGA-based accelerator is pin compatible to an Intel Socket 604 Xeon processor and is targeted for the new Intel Xeon 7300 series processors. (Wed, 14 Nov 2007 16:50:52 GMT)

Pullback from proteins
Genomics company Celera in Rockville, Maryland, has confirmed that it has laid off as many as half of its 50-odd proteomics researchers over the past six months. (Wed, 14 Nov 2007 16:59:12 GMT)

Ancient retroviruses spurred evolution of gene regulatory networks in humans and other primates
When ancient retroviruses slipped bits of their DNA into the primate genome millions of years ago, they successfully preserved their own genetic legacy. Today an estimated 8 percent of the human genetic code consists of endogenous retroviruses (ERVs)--the DNA remnants from these so-called "selfish parasites." (Wed, 14 Nov 2007 17:51:53 GMT)

Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline
SEATTLE , Nov. 14 /PRNewswire-FirstCall/ -- Analysts, fund managers, and investors heard first-hand the progress and prospects of three of Cell Therapeutics, Inc.'s (CTI) (Nasdaq: CTIC and MTAX: CTIC ) oncology drug candidates, as well as information on a drug CTI expects to acquire this year, from an international panel of clinical investigators at a Company-sponsored analyst day entitled "New ... (Wed, 14 Nov 2007 18:40:19 GMT)

Next Steps
Blood test a new tool for dementia patients Q: Over the past several years, my mother, now 83 years old, has becoming increasingly forgetful -- leaving the oven on, locking herself outside her house, losing her car keys, getting lost near her house and so on. (Wed, 14 Nov 2007 19:03:20 GMT)

Alpha Innotech Reports Record Third Quarter Revenues
SAN LEANDRO, Calif.----Alpha Innotech Corp. , a leading provider of bioanalytical systems for drug discovery and life science research, today reported financial results for the third quarter ending September 30, 2007. (Wed, 14 Nov 2007 20:03:00 GMT)

NCCR Launches Youth Education Campaign to Teach Genomics
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Wed, 14 Nov 2007 20:44:26 GMT)

Strategic Diagnostics Adjusts Quarter and Nine Months Ended September 30, 2007 Tax Expense
NEWARK, Del.----Strategic Diagnostics Inc. - today announced that it would make an adjustment to the tax expense as reported in its November 1, 2007 earnings release for the third quarter and nine months ended September 30, 2007, increasing the tax expense in both periods by $100,000. (Wed, 14 Nov 2007 21:01:00 GMT)

Africa: Continent Warms Up to Biotechnology
Much of the debate about biotechnology in Africa assumes that African countries are only being asked to accept products developed elsewhere. To the contrary, Freedom to Innovate: Biotechnology in Africa's Development shows that extensive biotechnology research is under way in Africa. (Wed, 14 Nov 2007 21:28:06 GMT)

Simple reason helps males evolve more quickly
GAINESVILLE, Fla. --- The observation that males evolve more quickly than females has been around since 19th century biologist Charles Darwin noted the majesty of a peacock’s tail feather in comparison with the plainness of the peahen’s. (Wed, 14 Nov 2007 21:58:07 GMT)

Predicting the future in ovarian cancer
Kisspeptin and its receptor GPR54 predict a favourable clinical outcome in women with ovarian carcinoma, and are specific for the clear cell carcinoma subtype, research published this week in the online open access journal, BMC Medicine, reveals. (Thu, 15 Nov 2007 01:15:21 GMT)

Rosetta Genomics Announces Initiation Of In Vivo Studies Following Successful Completion Of First Milestone In ...
Rosetta Genomics, Ltd. announced recently the initiation of in vivo studies in its MicroRNA-based liver cancer therapeutic program conducted in collaboration with Isis Pharmaceuticals. (Thu, 15 Nov 2007 06:06:41 GMT)

Proxeon and Bruker Daltonik Announce OEM Agreement: Bruker Daltonik to Offer Proxeon's EASY-nLC, a Nanoscale ...
Proxeon A/S and Bruker Daltonik GmBH today announced that the companies have entered into an OEM agreement. Under the agreement, Bruker Daltonik will sell Proxeon's nanoscale chromatography system, EASY-nLC(TM), together with their well-established range of products for mass spectrometry, beginning initially in the Europe region. (PRWeb Nov 14, 2007) Post Comment:Trackback URL: ... (Thu, 15 Nov 2007 06:48:39 GMT)

Interactive Library Offers a Look at Cancer, Neurons, Stem Cells
Web-based Flash interactives, developed by the Research department at Children's Hospital Boston, present complex ideas in a user-friendly format. (Thu, 15 Nov 2007 07:01:00 GMT)

Here's why males evolve more quickly than females across species
Washington, November 15 (ANI): A study of flies led by researchers at the University of Florida Genetics Institute has revealed that it is the simpler genetic makeup of males that makes them more attractive than females across species. The observation that males evolve more quickly than females has been in existence ever since 19th century biologist Charles Darwin pointed out the majesty of a ... (Thu, 15 Nov 2007 08:50:11 GMT)

Predicting The Future In Ovarian Cancer
Kisspeptin and its receptor GPR54 predict a favourable clinical outcome in women with ovarian carcinoma, and are specific for the clear cell carcinoma subtype, research published this week in the online open access journal BMC Medicine reveals. [click link for full article] (Thu, 15 Nov 2007 11:18:00 GMT)

Males Evolve More Quickly For Simple Reason
The observation that males evolve more quickly than females has been around since 19th century biologist Charles Darwin noted the majesty of a peacock's tail feather in comparison with the plainness of the peahen's.No matter the species, males apparently ramp up flashier features and more melodious warbles in an eternal competition to win the best mates, a concept known as sexual selection. ... (Thu, 15 Nov 2007 11:19:01 GMT)

UCI, companies see green
Local companies and UCI are teaming up to explore innovative ways to control pollution and cut oil consumption. (Thu, 15 Nov 2007 11:26:05 GMT)

DNAPrint(R) Genomics and Beckman Coulter Sign Sales and Marketing Agreement for DNAWitness(TM) and AncestryByDNA(TM)
DNAPrint® Genomics, Inc. today announced that it has entered into a sales and marketing agreement with Beckman Coulter, Inc., of Fullerton, CA, around DNAPrint's proprietary AncestryByDNA(TM) and DNAWitness(TM) technologies, utilizing Beckman Coulter's SNPStream® Genotyping Systems. (Thu, 15 Nov 2007 12:30:00 GMT)

Singulex Collaborates With Washington University School of Medicine to Advance Biomarker Research in Human Disease
Singulex Inc. today announced a collaboration with researchers at Washington University School of Medicine to increase the clinical utility of both validated and recently discovered biomarkers in human disease. (Thu, 15 Nov 2007 13:00:00 GMT)

Journal of Alzheimer's Disease special issue explores multifaceted aspects of AD
Amsterdam, November 15, 2007 – A recently published special issue of the Journal of Alzheimer's Disease contains the contributions from experts in the field of aging, dementia and Alzheimer’s disease, who attended the “Fourth Annual Meeting on Brain aging and Dementia: From successful aging to severe dementia.” (Thu, 15 Nov 2007 14:01:22 GMT)

Genome comparison of 12 fruit fly species
Researchers from the UAB Genomics, Bioinformatics and Evolution Group participated in an international research that has resulted in the completion of the genomes of ten new fruit fly species. (Thu, 15 Nov 2007 15:26:49 GMT)

Comptuer Scientists Use Data Mining to Advance Neuroinformatics
Computer scientists are creating new algorithms that will process the massive amounts of data neuroscientists are now able to collect from the brain. (Thu, 15 Nov 2007 17:27:38 GMT)

D- Lib Magazine
Illustration by Sergio Lobato, for an Access Excellence Mystery Spot written and directed by Ken Eklund. Courtesy of Access Excellence @ the National Health Museum. (Thu, 15 Nov 2007 17:35:40 GMT)

Landmark clinical trial
The ability of insulin to limit heart-tissue damage during a heart attack will be tested in a landmark clinical trial led by Paresh Dandona, UB Distinguished Professor in the departments of Medicine and Pharmacology and Toxicology in the School of Medicine and Biomedical Sciences. (Thu, 15 Nov 2007 17:44:19 GMT)

Research and Markets: Proteomics in Practice: A Guide to Successful Experimental Design, Second, Completely Revised ...
DUBLIN, Ireland----Research and Markets has announced the addition of Proteomics in Practice: A Guide to Successful Experimental Design, Second, Completely Revised Edition to their offering. (Thu, 15 Nov 2007 17:48:00 GMT)

Expression Analysis, Inc. Honored with Fast 50 Award
RALEIGH, N.C.----Expression Analysis, a leading global provider of genomic services for clinical trials, was recognized as one of the fastest growing private companies in the North Carolina Research Triangle at the Triangle Business Journal's annual Fast 50 Awards ceremony. (Thu, 15 Nov 2007 17:55:00 GMT)

Career Fair Focused on Ohio's Expanding Bioscience Industry
COLUMBUS, Ohio----The 2nd Annual Ohio Bioscience Career Fair will be held Tuesday, Nov. 27 at the Holiday Inn Columbus-Worthington. The Ohio Bioscience Career Fair will feature more than 20 Ohio bioscience-related companies with employment or internship openings. (Thu, 15 Nov 2007 18:19:00 GMT)

General Motors, Virginia Tech scientists collaborate to advance neuroinformatics
Advances in sensing technologies have made exquisite measurements of brain activity possible in the past decade. Using these measurements, computer scientists will now help neuroscientists discover the complex neuronal networks in the brain that result in the actions we take for granted, like reaching for a glass of water. (Thu, 15 Nov 2007 18:36:20 GMT)

RTI Wins $6.8M Grant for Genetics Project
RTI International scientists have won federal funding totaling nearly $7 million to develop standard measures for use in genetics research. (Thu, 15 Nov 2007 19:10:57 GMT)

VeriChip Corporation and Digital Angel Corporation to Disclose Additional Details on Implantable RFID Glucose-Sensing ...
DELRAY BEACH, Fla.----VeriChip Corporation , a provider of RFID systems for healthcare and patient-related needs, and Digital Angel Corporation , owner of Patent No. 7,125,382, announced today that they will host events for the medical and investment communities on December 4-5th in New York surrounding the development of an implantable bio-sensing RFID microchip to measure glucose levels in ... (Thu, 15 Nov 2007 20:03:00 GMT)

RTI Lands up to $6.8M NHGRI Grant to Create Population Genomics Standards
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Thu, 15 Nov 2007 20:42:26 GMT)

Agilent Technologies Reports Fourth Quarter 2007 Results
SANTA CLARA, Calif.----Agilent Technologies Inc. today reported orders of $1.48 billion for the fourth fiscal quarter ended Oct. 31, 2007, 6 percent above one year ago. Revenues during the quarter were $1.45 billion, 9 percent above last year. (Thu, 15 Nov 2007 21:05:00 GMT)

Why are males in evolutionary overdrive even though they have essentially the same genes as females?
The observation that males evolve more quickly than females has been around since 19th century biologist Charles Darwin noted the majesty of a peacock's tail feather in comparison with the plainness of the peahen's. (Fri, 16 Nov 2007 00:15:50 GMT)

One Step Closer to Staph Infection Vaccine
In the ongoing search for a vaccine to battle the aggressive methicillin-resistant staphylococcus aureus, a University of Southern Mississippi biological science professor and student have developed an online database that holds collected data on genes related to staph. (Fri, 16 Nov 2007 00:28:27 GMT)

What’s in your dog’s genes?
The science of DNA can be used to solve crimes, but also other mysteries – like identifying the breeds in the genes of that dog you affectionately call a mutt. (Fri, 16 Nov 2007 04:17:44 GMT)

Startup helps in search for effective diagnostics
Researchers at Washington University are using technology from a local biotech startup in the search for more effective diagnostic tests and treatments for cancer, diabetes and other ailments. (Fri, 16 Nov 2007 04:46:18 GMT)

Simple Reason Helps Males Evolve More Quickly
Evolutionary biologists have focused on sex differences since Darwin's "Origin of Species." A straightforward but seemingly underappreciated explanation for the ability of males to answer the call of sexual selection may be that their genetic machinery is simpler. (Fri, 16 Nov 2007 05:06:08 GMT)

Cero claims victory for Mercer Island Council slot
Mike Cero is claiming victory in the close race for Mercer Island City Council Position 3. Cero said he has received a congratulatory call... (Fri, 16 Nov 2007 08:41:31 GMT)

Hormone may predict favourable outcome for ovarian cancer
Washington, Nov16 (ANI): A recent study has found that Kisspeptin and its G-protein group receptor GPR54 are capable of predicting a favourable outcome in woman with ovarian carcinoma. Kisspeptins, a family of peptide hormones, and the receptor GPR54 were previously associated with anti-metastatic activity in certain human tumours. The study, at the BC Cancer Agency and Vancouver General ... (Fri, 16 Nov 2007 09:03:38 GMT)

Nicole Brown Simpson's untold 'Story'
Rush & Molloy: Nicole Brown Simpson's sister, Denise, has been condemning "If I Did It," the Judith Regan-edited O.J. memoir. Now we're getting the inside story that she approached Regan to pitch a book based on Nicole's diaries. (Fri, 16 Nov 2007 10:04:59 GMT)

Multifaceted Aspects Of AD Explored In Journal Of Alzheimer's Disease Special Issue
A recently published special issue of the Journal of Alzheimer's Disease contains the contributions from experts in the field of aging, dementia and Alzheimer's disease, who attended the "Fourth Annual Meeting on Brain aging and Dementia: From successful aging to severe dementia. [click link for full article] (Fri, 16 Nov 2007 12:19:03 GMT)

BioWisdom Launches OmniViz Academic Program
BioWisdom has launched an exclusive program that gives access to its OmniViz visualization and analysis software to academics and not-for-profit organisations at a heavily discounted price of $999. (Fri, 16 Nov 2007 12:48:00 GMT)

Company Offers Genome Assessments
An Icelandic company said today that it is launching a service that will assess a person?s genome for disease risk. (Fri, 16 Nov 2007 12:51:53 GMT)

Gene Express Appoints Larissa Karnaoukhova Director of Strategic Partnerships
Gene Express, Inc. today announced the appointment of Larissa Karnaoukhova, Ph.D. to Director of Strategic Partnerships. (Fri, 16 Nov 2007 14:13:00 GMT)

Collaboration By General Motors And Virginia Tech Scientists To Advance Neuroinformatics
Advances in sensing technologies have made exquisite measurements of brain activity possible in the past decade. Using these measurements, computer scientists will now help neuroscientists discover the complex neuronal networks in the brain that result in the actions we take for granted, like reaching for a glass of water. [click link for full article] (Fri, 16 Nov 2007 14:18:43 GMT)

Hormone may predict favourable outcome for ovarian cancer
Washington, Nov16 : A recent study has found that Kisspeptin and its G-protein group receptor GPR54 are capable of predicting a favourable outcome in woman with ovarian carcinoma. (Fri, 16 Nov 2007 15:41:44 GMT)

Understanding Allergies By Mapping Chemical Structures Recognized By Immune System
New research could lead to revolutionary new approaches for treating allergies based on targeting T cells, white blood cells that regulate the immune response. The project will map down to the level of molecules and atoms the chemical structures recognized by the immune system and which cause it to initiate an allergic reaction. (Fri, 16 Nov 2007 16:03:37 GMT)

Decode Throws Hat into Consumer Genomics Ring
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Fri, 16 Nov 2007 16:12:26 GMT)

Tuschl Wins Max Delbrueck Medal; Adam Joins Applera's Board; Ludesi Adds Proteomics Expertise; and Others
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Fri, 16 Nov 2007 20:57:26 GMT)

23andMe to Hold Webcast Media Briefing
MOUNTAIN VIEW, Calif.----23andMe, Inc., a privately-held personal genetics company dedicated to helping individuals understand their own genetic information through DNA analysis technologies and web-based interactive tools, announced today that it will officially launch its first product to consumers on Monday November 19th, 2007. (Fri, 16 Nov 2007 22:13:00 GMT)

Noticias Infobolsa / Titulares
16/11/2007 22:13:00 Business Wire 23andMe, Inc., a privately-held personal genetics company dedicated to helping individuals understand their own genetic information through DNA analysis technologies and web-based interactive tools, announced today that it will officially launch its first product to consumers on Monday November 19th, 2007. (Fri, 16 Nov 2007 22:16:41 GMT)

$1,000 buys a genetic glimpse into your past, future
A revolution in human genomics, though barely understood by professionals, is about to hit the street, at least for those able to pay about $1,000 for a glance at their entire genome. NEW ON THE MARKET Decode Genetics announced Friday that it is launching a service called deCODEme, which will assess a person's genome for disease risk, bodily traits such as hair and eye color, and ancestral ... (Sat, 17 Nov 2007 02:45:17 GMT)

Experts Advise a Grain of Salt With Mail-Order Genomes, at $1,000 a Pop
While people may welcome the rich new trove of data about their ancestry, genetic counselors are concerned that some people may find the information hard to handle. (Sat, 17 Nov 2007 03:41:42 GMT)

DNA test brings personal genome closer
The era of personal genomics came a step closer on Friday with the launch of the first commercial service to give people an extensive look at their own DNA for less than $1,000. (Sat, 17 Nov 2007 05:45:56 GMT)

Several firms stand ready to decode clients' genomes
The revolution in human genomics, though barely understood by professionals, is about to hit the street, at least for those able to pay about $1,000 for a glance at their entire genome. (Sat, 17 Nov 2007 06:11:10 GMT)

Medicine of the future Akonni Biosystems opens headquarters and laboratories in Frederick
The future of personal medicine may very well have its start in Frederick. That was a recurrent theme for speakers Friday at the opening of Akonni Biosystems' headquarters and laboratories on Sagner Avenue. A crowd of hundreds attended the event. (Sat, 17 Nov 2007 07:09:16 GMT)

23AndMe Will Decode Your DNA for $1,000. Welcome to the Age of Genomics
Reading your own genomic profile -- learning your predispositions for various diseases, odd traits and a talent or two -- is something like going to a phantasmagorical family reunion: grandparents who died before you were born, your parents, future versions of yourself, your children. A new service, drawing on new science, makes it possible to learn your genetic markers. ... (Sat, 17 Nov 2007 08:39:34 GMT)

Genomics Smackdown
One's genetically curious, the other calls "TMI!" Senior Wired News editor Kristen Philipkoski and Wired magazine's managing editor Jacob Young argue why they do -- and do not -- want to know more about their own genetic backgrounds or forecasts. Vote for the arguments you think are the strongest. (Sat, 17 Nov 2007 08:39:55 GMT)

Individuals can get genome map
By NICHOLAS WADE The revolution in human genomics, though barely understood by professionals, is about to hit the street, at least for those able to pay about $1,000 for a glance at their entire genome. The Icelandic company Decode Genetics announced Friday that it is starting a service called deCODEme, which will assess a person's genome for the risk of disease, traits such as hair and eye ... (Sat, 17 Nov 2007 11:52:36 GMT)

Fostering Collaboration
In anticipation of the explosive growth of biomedical science, Indiana University recently completed a new 140,000-sq.-ft. facility to support promising research initiatives for the diagnosis and treatment of disease. (Sat, 17 Nov 2007 21:02:17 GMT)

Philanthropist's gift to establish children's research center
A philanthropist who has already given $400 million to a Sioux Falls hospital system is setting aside another $20 million to establish a children's research center with locations in South Dakota and California. (Sun, 18 Nov 2007 06:45:50 GMT)

For $1,000, get genetic glimpse
The revolution in human genomics, though barely understood by professionals, is about to hit the street, at least for those able to pay about $1,000 for a glance at their entire genome. (Sun, 18 Nov 2007 07:30:28 GMT)

Search content
last 14 days. Murry Graham, the school’s audio-visual media specialist, supervises the class. His predecessor used to make the announcements himself, he said, but it took a lot of time. (Sun, 18 Nov 2007 07:40:19 GMT)

Howard Education Notes
(Sun, 18 Nov 2007 09:00:36 GMT)

Kisspeptin and GPR54 may be the future of ovarian cancer treatment
Kisspeptin and its receptor GPR54 predict a favourable clinical outcome in women with ovarian carcinoma, and are specific for the clear cell carcinoma subtype, research published this week in the online open access journal, BMC Medicine, reveals. (Sun, 18 Nov 2007 23:00:45 GMT)

From successful aging to severe dementia
A recently published special issue of the Journal of Alzheimer's Disease contains the contributions from experts in the field of aging, dementia and Alzheimer's disease, who attended the "Fourth Annual Meeting on Brain aging and Dementia - From successful aging to severe dementia”, Held in Perugia in October 2006 under the auspices of the Italian Psychogeriatric Association, a member of the ... (Sun, 18 Nov 2007 23:00:55 GMT)

DBT plans technology cluster for life sciences in Haryana
The Department of Biotechnology is in advanced stages of establishing four technology clusters including one for health sciences at Faridabad in Haryana and hoping to see them functional in a couple of years. (Mon, 19 Nov 2007 02:42:03 GMT)

People look at own DNA for less than $1,000
The era of personal genomics came a step closer on last Friday with the launch of the first commercial service to give people an extensive look at their own DNA for less than 1,000 U.S. dollars, media reported Monday. DeCode Genetics ... (Mon, 19 Nov 2007 05:46:22 GMT)

PolyPeptide Laboratories Group Acquires NeoMPS
PolyPeptide Laboratories Group, a leading global provider of custom and generic GMP-grade peptides for a range of pharmaceutical and biotechnology applications, today announced its acquisition of peptide manufacturing group NeoMPS from Isochem, the fine chemicals subsidiary of the French Groupe SNPE. NeoMPS operates facilities in France and the United States. (Mon, 19 Nov 2007 07:30:00 GMT)

Commercialization of Biotechnologies as Applied to Industrial Processes is the Next Wave According to New Report
DUBLIN, Ireland----Research and Markets has announced the addition of Comprehensive Analysis of R&D and Commercialization for Related Biotechnologies from Non-Biotechnology/Non-Pharmace Companies to their offering. (Mon, 19 Nov 2007 10:05:00 GMT)

RFID Chips: VeriChip Corporation And Digital Angel Corporation To Disclose Additional Details On Implantable RFID ...
VeriChip Corporation ("VeriChip"), a provider of RFID systems for healthcare and patient-related needs, and Digital Angel Corporation ("Digital Angel") , owner of Patent No. 7,125,382, announced recently that they will host events for the medical and investment communities on December 4-5 th in New York surrounding the development of an implantable bio-sensing RFID microchip to measure glucose ... (Mon, 19 Nov 2007 10:11:00 GMT)

23andMe Lets You Search and Share Your Genome — Today
SILICON VALLEY - Personal genomics is finally here. 23andMe, the Google-backed startup that promises to let individuals search and share their personal genetic information, just unveiled its service on its Web site. (Mon, 19 Nov 2007 12:26:51 GMT)

Wilson Sonsini Goodrich & Rosati Names 13 New Partners
Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprises worldwide, today announced that it has elected 13 new partners. (Mon, 19 Nov 2007 13:00:00 GMT)

23andMe Launches Web-Based Service Empowering Individuals to Access and Understand Their Own Genetic Information
MOUNTAIN VIEW, Calif.----23andMe, Inc., a privately-held personal genetics company, announced today that it has officially launched and has begun offering its services directly to consumers in the United States. 23andMe is helping individuals understand their own genetic information through the latest advances in DNA analysis and web-based interactive tools. (Mon, 19 Nov 2007 13:00:00 GMT)

Boost Biosystems - creating a strategy for public-private collaboration in Medicon Valley
Medicon Valley has a significant development potential within Biosystems technology. However, to utilize this potential demands closer collaboration between universities, industries and the intermediate support systems. (Mon, 19 Nov 2007 13:49:37 GMT)

JMP(R) Genomics 3.1 Adds New DNA Analysis Tools
CARY, N.C.----JMP Genomics 3.1 gives scientists important new tools in their quest to understand the causes of human disease. This update of SAS' all-in-one genomics software for the desktop includes capabilities for analyzing the number of copies of a particular gene or chromosomal region in an individual's DNA. (Mon, 19 Nov 2007 14:00:00 GMT)

CombiMatrix Begins Trading On the Nasdaq Global Market
MUKILTEO, Wash., Nov. 19, 2007 -- CombiMatrix Corporation announced today that its common stock will begin trading on the Nasdaq Global Market effective today, November 19, 2007. Previously, the Company's stock had been trading on the Nasdaq Capital Market. (Mon, 19 Nov 2007 14:00:00 GMT)

Fledgling Consumer Genomics Field Fattens up with 23andMe Service Launch
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Mon, 19 Nov 2007 15:57:16 GMT)

Predicting The Future In Ovarian Cancer
Kisspeptin and its receptor GPR54 predict a favorable clinical outcome in women with ovarian carcinoma, and are specific for the clear cell carcinoma subtype according to a new article. (Mon, 19 Nov 2007 16:03:08 GMT)

Accelerated computing platform for Intel FSB rolls
Xilinx Inc. has begun commercial licensing of the high-performance computing industry's first FPGA-based acceleration solution to interface with the Intel Front Side Bus (FSB). (Mon, 19 Nov 2007 21:08:10 GMT)

Breakthrough in organ rejection diagnosis examines gene behavior
A new article appearing in American Journal of Transplantation describes a revolutionary technique for more clearly identifying the possibility of organ rejection in kidney transplants. The technique, which uses a microarray or “Gene Chip,” a process of examining DNA sequences, defines how major causes of organ disease leading to rejection share similar disturbances in gene behavior. (Mon, 19 Nov 2007 21:51:50 GMT)

Lucile Packard Children's Hospital to get nearly $1.1M from HP foundation
Hewlett-Packard and Lucile Packard Children's Hospital said Monday the Palo Alto pediatric hospital will receive nearly $1.1 million in cash and technology from HP and its company foundation, including gifts of HP computers, monitors and printers. (HPQ) (Mon, 19 Nov 2007 23:00:36 GMT)

News.com Extra: Electronics recycling 'horrific'
Plus: The evolution of the CIO. Read these stories and more from around the Web on News.com Extra. (Mon, 19 Nov 2007 23:42:44 GMT)

Breakthrough In Organ Rejection Diagnosis Examines Gene Behavior
A new technique improves the identification of possible organ rejection in kidney transplants. The technique, which uses a microarray or “Gene Chip,” a process of examining DNA sequences, defines how major causes of organ disease leading to rejection share similar disturbances in gene behavior. (Tue, 20 Nov 2007 01:04:48 GMT)

PolyPeptide Laboratories Group Acquires NeoMPS
PolyPeptide Laboratories Group, a leading global provider of custom and generic GMP-grade peptides for a range of pharmaceutical and biotechnology applications, recently announced its acquisition of peptide manufacturing group NeoMPS from Isochem, the fine chemicals subsidiary of Paris-based Groupe SNPE. NeoMPS operates facilities in France (Strasbourg) and the United States (San Diego). (Tue, 20 Nov 2007 05:21:28 GMT)

Students' Genomics Tool Will Lead To Better Medicine
While consumers and pharmacists are well aware that prescription drug interactions can be dangerous, the fact that each person's genetic makeup can render certain drugs dangerous or even deadly is not widely recognized. [click link for full article] (Tue, 20 Nov 2007 10:18:53 GMT)

Breakthrough In Organ Rejection Diagnosis Examines Gene Behavior
A new article appearing in American Journal of Transplantation describes a revolutionary technique for more clearly identifying the possibility of organ rejection in kidney transplants. The technique, which uses a microarray or "Gene Chip," a process of examining DNA sequences, defines how major causes of organ disease leading to rejection share similar disturbances in gene behavior. [click link ... (Tue, 20 Nov 2007 10:19:03 GMT)

Nonlinear Dynamics and PerkinElmer Support Market Interest in 2D for Proteomics by Supplying Progenesis SameSpots ...
Nonlinear Dynamics Ltd, the company meeting the analysis challenges in proteomics, biomarker discovery and clinical diagnostics today announced that PerkinElmer, Inc. (Waltham, USA) will supply Progenesis SameSpots with the Geliance 1000 Imaging System, which was launched at the recent HUPO 6th Annual Congress. (Tue, 20 Nov 2007 11:09:00 GMT)

Utrecht University Licenses MetaDrug From GeneGo for Drug Innovation
GeneGo, Inc., the leading provider of databases, software and services in systems biology, announced today that Utrecht University will be using MetaDrug in their prestige master program for drug innovation. (Tue, 20 Nov 2007 12:00:00 GMT)

Looking for diseases in DNA hiccups
WASHINGTON -- Your DNA has the hiccups. It stutters, gags, repeats itself and skips stuff like a nervous teenager giving a speech in school. (Tue, 20 Nov 2007 12:56:35 GMT)

Rosetta Genomics and NYU School of Medicine Expand Their microRNA-Based Collaboration to Include Cardiovascular ...
Rosetta Genomics, Ltd. and NYU School of Medicine announced today they have expanded their collaboration to include congenital heart disease . Applying Rosetta Genomics innovative microRNA extraction protocols from various body fluids and NYU School of Medicine's vast experience in this field, this collaboration will screen for specific microRNA biomarkers and signatures that may be used to ... (Tue, 20 Nov 2007 13:30:00 GMT)

Affymetrix to Webcast Presentation at Piper Jaffray Health Care Conference
SANTA CLARA, Calif.----Affymetrix Inc. today announced that Doug Farrell, vice president of investor relations, will provide a company overview at the Piper Jaffray Health Care Conference on November 27, 2007 in New York City. (Tue, 20 Nov 2007 14:00:00 GMT)

Invitrogen Corporation (IVGN) Chairman and Chief Executive Officer to Ring the NASDAQ Stock Market Opening Bell
ADVISORY, Nov. 20, 2007 -- (Tue, 20 Nov 2007 15:00:00 GMT)

Chancellor says U branch will be agile
In his first extended comments about his plans for the university, University of Minnesota-Rochester Chancellor Stephen Lehmkuhle offered a glimpse of the (Tue, 20 Nov 2007 15:20:51 GMT)

NAU, TGen win $4.5M grant
A bacterium called Burkholderia pseudomallei lives in the surface waters and soils of Southeast Asia, causing pneumonia, bloodstream infections and sometimes death among farmers, soldiers and travelers. (Tue, 20 Nov 2007 16:29:05 GMT)

Scientists Turn Human Skin Cells Into Stem Cells
TUESDAY, Nov. 20 (HealthDay News) -- Two separate groups of scientists have succeeded in turning human skin cells into cells that are very similar -- but not identical -- to embryonic stem cells. (Tue, 20 Nov 2007 17:00:15 GMT)

Emerging Research Highlights How Race, Ethnicity and Socio-economic Factors Affect Cancer Outcomes
The latest biological, clinical and social research behind how cancer affects different racial and ethnic groups will be the focus of the first American Association for Cancer Research conference on the topic, entitled "The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved." The meeting is to be held November 27 to 30 at the Atlanta Marriott Marquis ... (Tue, 20 Nov 2007 18:21:06 GMT)

News.com Extra: Yes, Google is trying to take over wireless
Plus: Ten greatest hoax gadgets of all time. Read these stories and more from around the Web on News.com Extra. (Tue, 20 Nov 2007 19:02:07 GMT)

Scientists Turn Human Skin Cells Into Stem Cells
By Amanda Gardner , HealthDay Reporter TUESDAY, Nov. 20 (HealthDay News) -- Two separate groups of scientists have succeeded in turning human skin cells into cells... (Tue, 20 Nov 2007 19:07:14 GMT)

Rosetta Genomics, NYU Add Neonatal Heart Disorder to miRNA Cancer Alliance
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Tue, 20 Nov 2007 21:27:26 GMT)

IBM links researchers, African students
When technology companies talk up the potential of the developing world, they usually mean places that already are hotbeds like China or India. IBM Corp. is placing bets on African countries where it has launched a mentoring program for college students. The project, called Makocha Minds, using the Swahili word for "teachers," puts 250 of IBM's top researchers in regular contact with ... (Tue, 20 Nov 2007 21:50:04 GMT)

Gene chips provide new technique to evaluate organ rejection in kidney transplants
A new article appearing in American Journal of Transplantation describes a revolutionary technique for more clearly identifying the possibility of organ rejection in kidney transplants. (Tue, 20 Nov 2007 23:15:55 GMT)

BOSTON (AP) -- When technology companies talk up the potential of the developing world, they usually mean places that ...
IBM Corp. is placing bets on African countries where it has launched a mentoring program for college students. (Wed, 21 Nov 2007 00:03:08 GMT)

Ripening secrets of the vine revealed
Whether you prefer a Cabernet Sauvignon or a Pinot Noir grape variety, two new research articles published in the online open access journal, BMC Genomics, offer a host of new genetic information on fruit ripening for this economically important fruit crop. (Wed, 21 Nov 2007 05:14:29 GMT)

GNI Announces IND Approval in China for Novel Liver Disease Drug F351
GNI Ltd (TOKYO:2160), a leading biopharmaceutical company in Japan and China, is pleased to announce that the State Food and Drug Administration of China has approved its Investigational New Drug application (IND) for the clinical development of one of its lead drug candidates, F351, for the treatment of liver fibrosis/cirrhosis. GNI's China-based affiliate, Shanghai Genomics, is in the process ... (Wed, 21 Nov 2007 07:32:00 GMT)

Scientists Decode Genomes Of Diverse TB Isolates
An international collaboration led by researchers in the US and South Africa announced the first genome sequence of an extensively drug resistant (XDR) strain of the bacterium Mycobacterium tuberculosis, one linked to more than 50 deaths in a recent tuberculosis (TB) outbreak in KwaZulu-Natal, South Africa. [click link for full article] (Wed, 21 Nov 2007 11:19:27 GMT)

Brostallicin Trial Data Demonstrates Encouraging Anti-tumor Activity in Patients With Chemotherapy-Resistant Cancers
Systems Medicine, LLC , a wholly-owned subsidiary of Cell Therapeutics, Inc. , announced that cumulative preliminary results of a phase I trial combining cisplatin with brostallicin in patients with solid tumors that had relapsed or were resistant to front-line treatment were presented at the Highlights in Oncology meeting in Naples, Italy, on Tuesday, November 20, 2007. (Wed, 21 Nov 2007 12:00:00 GMT)

Briefs: FSA executive, food fraud and the stilton shake
20/11/2007 - In this week's briefs, a former executive of Arla Foods is appointed to the UK's Food Standards Agency, the industry prepares to gather to discuss food fraud, and stilton cheese gets a shake up. (Wed, 21 Nov 2007 12:16:43 GMT)

Rosetta announces expansion of NYU collaboration
Collins Stewart notes that the biotech firm and the NYU School of Medicine will develop cardiovascular diagnostic tests, lending validity to the the microRNA program. (Wed, 21 Nov 2007 12:47:20 GMT)

IBM mentors African students
Makocha Minds, using the Swahili word for "teachers," puts 250 of IBM's top researchers in regular contact with engineering, math and computing students at universities in ten African countries. (Wed, 21 Nov 2007 12:51:38 GMT)

IBM links researchers, African students
BOSTON, Massachusetts (AP) -- IBM Corp. is placing bets on African countries where it has launched a mentoring program for college students. (Wed, 21 Nov 2007 14:43:20 GMT)

UMass Medical launches bioinformatics program
The University of Massachusetts Medical School has started a bioinformatics and integrative biology program, officials say. (Wed, 21 Nov 2007 16:15:48 GMT)

News.com Extra: Writers' strike priced at $21 million a day
Plus: New Hitachi robot rolls around, crashes. Read these stories and more from around the Web at News.com Extra. (Wed, 21 Nov 2007 18:02:07 GMT)

Brostallicin Trial Data Demonstrates Encouraging Anti-tumor Activity in Patients With Chemotherapy-Resistant Cancers
SEATTLE , Nov. 21 /PRNewswire-FirstCall/ -- Systems Medicine, LLC (SM), a wholly-owned subsidiary of Cell Therapeutics, Inc. (CTI) (Nasdaq: CTIC; MTAX), announced that cumulative preliminary results of a phase I trial combining cisplatin with brostallicin in patients with solid tumors that had relapsed or were resistant to front-line treatment were presented at the Highlights in Oncology meeting ... (Wed, 21 Nov 2007 20:25:05 GMT)

Oklahoma Group Puts $900K into Local Genomics Research
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Wed, 21 Nov 2007 21:12:36 GMT)

News: Is Disease "Inheritance" More Random than Once Thought?
Random and frequent cellular deactivation of one of two gene copies could potentially change a genetic outcome New research shows that cells often randomly deactivate one of a pair of gene copies or alleles, one of which they get from mom, the other from dad. This inactivation may potentially help explain why some children in a family may exhibit certain heritable disorders, whereas others do ... (Wed, 21 Nov 2007 21:19:39 GMT)

Here Comes Pond Scum Power
Algae biodiesel isn't practical yet, but startups and giants are enthusiastically exploring the possibilities (Wed, 21 Nov 2007 23:34:47 GMT)

Blind mice shed light on human sight loss
Mutant mice could provide genetic clues to understanding incurable human sight loss resulting from retinal degeneration. Research published in the online open access journal Genome Biology uncovers a role for microRNA in retinal disease, and may point the way to future therapies. (Thu, 22 Nov 2007 01:14:58 GMT)

Aging populace poses challenges to nation
From left: Jordan Ter, co-chair of the AmCham Pharmaceutical Committee; Twu; and Melt van der Spuy, co-chair of the AmCham Pharmaceutical Committee, at an AmCham luncheon yesterday. (Thu, 22 Nov 2007 02:46:57 GMT)

Rosetta and NYU School of Medicine collaborate on heart diseases
Rosetta Genomics and NYU School of Medicine have expanded their collaboration to screen for specific microRNA biomarkers and signatures that may be used to diagnose and target congenital heart disease in newborns. (Thu, 22 Nov 2007 03:03:15 GMT)

Blind Mice Shed Light On Human Sight Loss
Mutant mice could provide genetic clues to understanding incurable human sight loss resulting from retinal degeneration. Scientists uncover a role for microRNA in retinal disease, and may point the way to future therapies. (Thu, 22 Nov 2007 04:03:27 GMT)

Medical schools join forces
The University of Virginia School of Medicine and Eastern Virginia Medical School have formed a partnership that is expected to boost federal research funding, expand clinical trials for experimental drugs and lead to medical research breakthroughs. "This is a nice opportunity for both institutions to take advantage of the strengths at the two places," said Dr. Ron Turner, U.Va.'s senior ... (Thu, 22 Nov 2007 05:24:15 GMT)

Brostallicin Trial Data Demonstrates Encouraging Anti Tumor Activity In Patients With Chemotherapy Resistant Cancers
Systems Medicine, LLC (SM), a wholly-owned subsidiary of Cell Therapeutics, Inc. [click link for full article] (Thu, 22 Nov 2007 09:17:52 GMT)

Scientists uncover microRNA role in sight loss
Washington, November 22 (ANI): A collaborative research has uncovered a role for microRNA in retinal disease. The study conducted by researchers from the Trinity College Dublin and the Sanger Institute, Cambridge (UK), was focused on mutant mice that model the human eye disease retinitis pigmentosa (RP). Retinitis pigmentosa is the most common form of inherited retinal degeneration. Mutations ... (Thu, 22 Nov 2007 09:54:14 GMT)

Genedata and Japanese venture on metastatic biomarkers
Swiss-based research informatics provider Genedata announced its collaboration with Tokyo Medical University, AMR Inc., and Leica Microsystems in a proteomics research initiative aiming at the identification of metastatic biomarkers for the discovery and validation of new protein drug targets. (Thu, 22 Nov 2007 09:56:57 GMT)

GNI Announces IND Approval In China For Novel Liver Disease Drug F351
GNI Ltd (TOKYO:2160), a leading biopharmaceutical company in Japan and China, is pleased to announce that the State Food and Drug Administration of China has approved its Investigational New Drug application (IND) for the clinical development of one of its lead drug candidates, F351, for the treatment of liver fibrosis/cirrhosis. [click link for full article] (Thu, 22 Nov 2007 10:18:53 GMT)

Light Shone On Human Sight Loss By Blind Mice
Mutant mice could provide genetic clues to understanding incurable human sight loss resulting from retinal degeneration. Research published in the online open access journal Genome Biology uncovers a role for microRNA in retinal disease, and may point the way to future therapies. [click link for full article] (Thu, 22 Nov 2007 10:19:53 GMT)

Illumina to Present at the 2007 Piper Jaffray Healthcare Conference in New York City
SAN DIEGO----Illumina, Inc. announced today that the Company will webcast its presentation at the November 28, 2007 Piper Jaffray Healthcare Conference in New York, New York. At this conference, Christian Henry, Illumina's Senior Vice President and Chief Financial Officer, will provide an overview of the Company and participate in a brief question and answer session. (Thu, 22 Nov 2007 11:00:00 GMT)

Illumina to Present at the 2007 Piper Jaffray Healthcare Conference in New York City
Illumina, ( Nachrichten ) Inc. (NASDAQ:ILMN) announced today that the Company will webcast its presentation at the November 28, 2007 Piper Jaffray ( Nachrichten ) Healthcare Conference in New York, New York. At this conference, Christian Henry, Illumina ' s Senior Vice President and Chief Financial Officer, will provide an overview of the Company and participate in a brief question and answer ... (Thu, 22 Nov 2007 11:08:14 GMT)

Fat Hormone May Contribute To Longevity
Both humans and mice that manage to live to a ripe, old age show a clear change in their glucose metabolism, but it's unclear whether this change alone can increase lifespan. Using a mouse model of longevity, Terry Combs and colleagues report that changes in metabolism can indeed increase longevity. [click link for full article] (Thu, 22 Nov 2007 11:20:23 GMT)

3-day Bangalore Bio from April 24, 2008 in Bangalore
The 8th mega biotechnology flagship event 'Bangalore Bio 2008' is scheduled to be held in Bangalore from April 24 to 26, 2008. The event, which is expected to witness participation from around 20 countries, will focus on fostering global partnerships. (Thu, 22 Nov 2007 12:41:53 GMT)

Wageningen, The Netherlands November 19, 2007 Wageningen University and Research Centre
(Wageningen UR) has announced that it is investing in ‘second generation’ equipment for DNA sequencing (determining the order of the building blocks (‘bases’) of genetic material). (Thu, 22 Nov 2007 20:46:43 GMT)

GNI receives approval for liver disease drug
The State Food and Drug Administration of China has approved GNIs investigational new drug application for the clinical development of the biopharmaceutical companys drug candidate for the treatment of liver fibrosis. (Fri, 23 Nov 2007 02:18:53 GMT)

Story Ideas from the Journal of Biological Chemistry
1) Fat Hormone may Contribute to Longevity; 2) Unraveling the Silky Spider's Web. (Fri, 23 Nov 2007 05:27:37 GMT)

Techbits
LG.Philips to make clean notebook screenSEOUL, South Korea -- Tired of irritating smudges, dust and fingerp... (Fri, 23 Nov 2007 05:36:43 GMT)

Top Scoops
The wave of bio-fuels continues to advance, not because it is good for the environment or offers some solution to global climate change - de facto it will worsen it - but rather because the most powerful industries on the planet see it as a source of juicy profits and so make sure that many governments help them with laws and subsidies. (Fri, 23 Nov 2007 06:17:06 GMT)

Rebuilding The Evolutionary History Of HIV 1 Unravels A Complex Loop
An essential component of the human immunodeficiency virus (HIV-1) molecular machinery responsible for infecting cells consists of functionally-specialized layers, according to a study by investigators at the University of California San Diego (UCSD) Antiviral Research Center (AVRC), published November 23 in PLoS Computational Biology. [click link for full article] (Fri, 23 Nov 2007 09:02:42 GMT)

Previous 1 2 3 4 Next